Pharmaceutical Sector

Drug Partnership Extended by Regeneron and Sanofi

The partnership which was originally to end in 2012, has been extended by Regeneron Pharmaceuticals Inc. and French drug-maker Sanofi-Aventi, a news confirmed by both the companies, to 2017. The partnership has been extended to help Regeneron develop various experimental drugs which could prove to be much beneficial.

Julphar plans H1N1 vaccine output in fiscal 2010

Julphar, leading UAE's Gulf Pharmaceutical Industries has announced that it will soon commence producing an H1N1 vaccine early in year 2010.

Functionaries of Julphar stated in a communiqué that the company will begin production after getting the technology and raw materials required for the vaccine in January.

The sources informed that last week Julphar had purchased exclusive rights to make an H1N1 vaccine from China's Hualan Biological.

Neopharma gets clearance from UAE Ministry for Oseltamivir BR Flu

Neopharma, a premier pharmaceuticals manufacturing company based in Abu Dhabi, has notified that it has received clearance from the UAE Ministry of Health for its antiviral medication Oseltamivir BR Flu.

It should be noted that the ministry's approval for Neopharma's drug comes at a time when the entire region is gripped by fears over the H1N1 pandemic. 

The company claims that drug is a preferred option to prevent and treat H1N1 flu in the region. 

UAE and Saudi expansion mulled by Dubai pharmacy firm

As per the media reports, Dubai pharmacy firm is planning to expand in UAE and Saudi Arabia.

The company, which is a joint venture between Julphar and the private equity division of Global Investment House, specified that in the Middle East, it would be the largest pharmacy chain.

It has been learnt that the first 10 pharmacies, called Health First, are scheduled to open in Dubai and Abu Dhabi by December.

Abu Dhabi welcomes the launch of cancer drug by Biocon

Biocon, NeopharmaOn Thursday, India's Biocon Ltd in partnership with Abu Dhabi-based Company Neopharma, launched a drug for cancer, in Abu-Dhabi.